We are thrilled to announce the appointment of Stephen Dowd, PhD, MBA, as our Chief Business Officer (CBO) effective September 12, 2023. Stephen’s 25 years of experience working in biotechnology and pharmaceutical companies will be a valuable asset as we continue to advance our promising pipeline and maximize the value of our proprietary discovery platform. We look forward to welcoming Stephen to our Executive Team and to working together towards our goal of addressing a broader array of critical unmet medical needs. For more information on this announcement, please find our press release here: https://lnkd.in/eSYnxwfe
Congrats, Steve, Confo is lucky to have you!
Great news. Congratulations! All the best for the future.
Congratulations Stephen Dowd !
Congratulations Stephen!
Congratulations Steve!!
Director of the VIB-VUB center of Structural Biology, Professor of Biochemistry at the VUB, ERC Investigator, EMBO member
1yNice to see the team growing!